Supplementary Table 1 from Erlotinib Prolongs Survival in Pancreatic Cancer by Blocking Gemcitabine-Induced MAPK Signals
crossref（2023）
摘要
Supplementary Table 1 PDF file - 108K, Adding erlotinib to gemcitabine synergistically inhibited the growth of mouse and human PDAC cells
查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要